PARAMETRIC PORTFOLIO ASSOCIATES LLC - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 91 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2016. The put-call ratio across all filers is 0.41 and the average weighting 0.0%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q1 2019$55,000
-70.6%
40,829
-75.3%
0.00%
Q4 2018$187,000
-48.2%
165,525
+26.7%
0.00%
Q3 2018$361,000
-28.5%
130,633
-7.6%
0.00%
Q2 2018$505,000
+42.3%
141,453
+22.2%
0.00%
Q1 2018$355,000
-33.5%
115,798
+36.6%
0.00%
-100.0%
Q4 2017$534,000
+15.3%
84,741
+25.3%
0.00%0.0%
Q3 2017$463,000
-6.7%
67,628
-2.8%
0.00%0.0%
Q2 2017$496,000
-13.6%
69,595
+11.5%
0.00%0.0%
Q1 2017$574,000
+180.0%
62,423
+22.5%
0.00%
Q4 2016$205,000
+10.2%
50,965
+4.7%
0.00%
Q3 2016$186,000
+45.3%
48,656
+63.1%
0.00%
Q2 2016$128,000
+60.0%
29,841
+178.9%
0.00%
Q3 2015$80,000
-91.0%
10,699
-42.8%
0.00%
-100.0%
Q2 2015$887,000
+63.7%
18,694
+26.4%
0.00%
+100.0%
Q1 2015$542,000
-5.1%
14,792
+2.9%
0.00%0.0%
Q4 2014$571,00014,3750.00%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q3 2016
NameSharesValueWeighting ↓
Opaleye Management Inc. 330,000$2,353,0000.98%
EcoR1 Capital, LLC 633,400$4,516,0000.80%
DLD Asset Management, LP 570,000$4,059,0000.53%
Rhenman & Partners Asset Management AB 300,000$2,139,0000.31%
Eventide Asset Management 600,000$4,278,0000.27%
Tekla Capital Management LLC 1,004,322$7,161,0000.26%
Rock Springs Capital Management LP 698,000$4,977,0000.25%
DLD Asset Management, LP 230,000$1,640,0000.21%
Worth Venture Partners, LLC 29,325$209,0000.18%
Crestline Management, LP 161,403$1,151,0000.15%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders